Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 1 October 2002
Vol. 2002, Issue 152, p. tw354
[DOI: 10.1126/stke.2002.152.tw354]


Cardiophysiology Two PI3K Signals: One for Size and One for Strength

Cardiac hypertrophy is associated with many types of heart disease and can ultimately lead to cardiac decompensation and heart failure. One pathway important for the regulation of cell size is the phosphoinositide 3-kinase (PI3K) pathway acting through a signaling cascade that includes protein kinase B (PKB, also known as Akt), glycogen synthase kinase 3β (GSK-3β), and S6 kinase (p70S6K). Crackower et al. analyzed mice with cardiac and skeletal muscle-targeted deletion of the lipid phosphatase PTEN (mckCRE-PTEN{Delta}/{Delta}) that is responsible for termination of PI3K signaling by dephosphorylation of phosphatidylinositol 3-phosphate (PIP3), the product of PI3K activity. The mckCRE-PTEN{Delta}/{Delta} mice had enlarged hearts without any evidence of cardiomyopathy or cardiac decompensation and enhanced phosphorylation of PKB, GSK-3β, and p70S6K. These mice also had decreased cardiac contractility. Increased cardiac contractility was evident in mice deficient for the G protein-coupled receptor (GPCR)-regulated isoform of the catalytic subunit of PI3K, p110{gamma}. Double-mutant mice with both the cardiac PTEN deficiency and the p110{gamma} deficiency showed enlarged hearts without the decreased contractility seen in the mckCRE-PTEN{Delta}/{Delta} mice. The effect of the PTEN deficiency on heart size was eliminated in mice expressing dominant-negative p110α, the isoform coupled to receptor tyrosine kinases. Thus, there appear to be two PI3K pathways: one that regulates size through PIP3 produced by p110α and one that regulates contractility through PIP3 produced by p110{gamma}. Further investigation of the signaling pathway downstream of p110{gamma} suggested the involvement of adenosine 3',5'-monophosphate (cAMP) and regulation of the β2-adrenergic receptor in the enhanced contractility seen in the p110{gamma}-/- mice.

M. A. Crackower, G. Y. Oudit, I. Kozieradzki, R. Sarao, H. Sun, T. Sasaki, E. Hirsch, A. Suzuki, T. Shioi, J. Irie-Sasaki, R. Sah, H.-Y. M. Cheng, V. O. Rybin, A. J. Oliveira-dos-Santos, J. L. Benovic, C. R. Kahn, S. Izumo, S. F. Steinberg, M. P. Wymann, P. H. Backx, J. M. Penninger, Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110, 737-749 (2002). [Online Journal]

Citation: Two PI3K Signals: One for Size and One for Strength. Sci. STKE 2002, tw354 (2002).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882